References
- Jackson JA, Kleerekoper M. Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine (Baltimore) 1990: 69(3): 137–52
- Mazess RB, Barden HS, Drinka PJ, et al. Influence of age and body weight on spine and femur bone mineral density in US white men. J Bone Miner Res 1990: 5(6): 645–52
- Matkovic V, Kostial K, Simonovic I, et al. Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutr 1979: 32(3): 540–9
- Orwoll ES, Oviatt SK, McClung MR, et al. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med 1990: 112(1): 29–34
- Orwoll ES, Meier DE. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia. J Clin Endocrinol Metab 1986: 63(6): 1262–9
- Rudman D, Rudman IW, Mattson DE, et al. Fractures in the men of a Veterans Administration nursing home: relation to 1,25-dihydroxyvitamin D. J Am Coll Nutr 1989: 8(4): 324–34
- Bevier WC, Wiswell RA, Pyka G, et al. Relationship of body composition, muscle strength, and aerobic capacity to bone mineral density in older men and women. J Bone Miner Res 1989: 4(3): 421–32
- Orwoll ES, Ferar J, Oviatt SK, et al. The relationship of swimming exercise to bone mass in men and women. Arch Intern Med 1989: 149(10): 2197–200
- Seeman E, Melton LJ 3d, O'Fallon WM, et al. Risk factors for spinal osteoporosis in men. Am J Med 1983: 75(6): 977–83
- Laitinen K, Lamberg-Allardt C, Tunninen R, et al. Effects of 3 weeks' moderate alcohol intake on bone and mineral metabolism in normal men. Bone Miner 1991: 13(2): 139–51
- Lindholm J, Steiniche T, Rasmussen E, et al. Bone disorder in men with chronic alcoholism: a reversible disease? J Clin Endocrinol Metab 1991: 73(1): 118–24
- Ringe JD, Welzel D. Salmon calcitonin in the therapy of corticoid-induced osteoporosis. Eur J Clin Pharmacol 1987: 33(1): 35–9
- Reid IR, King AR, Alexander CJ, et al. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-l, 1-bisphosphonate (APD). Lancet 1988: 1(8578): 143–6
- Finkelstein JS, Neer RM, Biller BM, et al. Osteopenia in men with a history of delayed puberty. N Engl J Med 1992: 326(9): 600–4
- Vermeulen A. Clinical review 24: androgens in the aging male. J Clin Endocrinol Metab 1991: 73(2): 221–4
- Stanley HL, Schmitt BP, Poses RM, et al. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991: 39(8): 766–71
- Jackson JA, Riggs MW, Spiekerman AM. Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 1992: 304(1): 4–8
- Stepan JJ, Lachman M, Zverina J, et al. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989: 69(3): 523–7
- Jackson JA, Kleerekoper M, Parfitt AM, et al. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 1987: 65(1): 53–8
- Finkelstein JS, Klibanski A, Neer RM, et al. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989: 69(4): 776–83
- Greenspan SL, Oppenheim DS, Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 1989: 110(7): 526–31
- Gilman A, Goodman LS, Rail TW, et al, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed. New York: Macmillan, 1985
- Meikle AW, Mazer NA, Moellmer JF, et al. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men. J Clin Endocrinol Metab 1992: 74(3): 623–8
- Papapoulos SE, Landman JO, Bijvoet OL, et al. The use of bisphosphonates in the treatment of osteoporosis. Bone 1992: 13(Suppl 1): 41–9S